サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1543971

羊水穿刺針の世界市場

Amniocentesis Needles

出版日
ページ情報
英文 182 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
羊水穿刺針の世界市場
出版日: 2024年08月29日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

羊水穿刺針の世界市場は2030年までに2億1,300万米ドルに達する見込み

2023年に1億8,390万米ドルと推定される羊水穿刺針の世界市場は、2030年には2億1,300万米ドルに達し、分析期間2023-2030年のCAGRは2.1%で成長すると予測されます。本レポートで分析したセグメントの1つである150mm以上の針は、CAGR 2.4％を記録し、分析期間終了までに6,730万米ドルに達すると予測されています。100～150mmニードルセグメントの成長率は、分析期間中CAGR 1.9％と推定されます。

米国市場は4,860万米ドルと推定、中国はCAGR 2.0％で成長予測

米国の羊水穿刺針市場は、2023年に4,860万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに3,430万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは2.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.0％と1.7％と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界の羊水穿刺針市場- 主要動向と促進要因のまとめ

なぜ羊水穿刺針は妊産婦ケアにおいて重要なのか？

羊水穿刺針は、出生前診断において羊水を採取して検査するために使用される重要な医療機器です。この検査は、胎児の染色体異常、遺伝性疾患、感染症などを発見するのに役立ち、妊婦の両親やヘルスケアプロバイダーに貴重な情報を提供します。通常、羊水穿刺は妊娠15週目から20週目の間に行われ、超音波検査によって誘導されながら、母親の腹部から羊膜嚢に細い針を挿入します。採取された羊水には胎児の細胞や赤ちゃんが産生する様々な化学物質が含まれており、豊富な診断データが得られます。これらの針の重要性はその精度と安全性にあり、正確な結果を得ると同時に、母体と胎児の両方に対するリスクを最小限に抑えなければならないからです。

技術革新はどのように羊水穿刺針を向上させているか？

技術の進歩は、羊水穿刺針のデザインと機能性を大きく向上させています。材料科学の革新により、より細く、より柔軟で、より耐久性のある針が開発され、患者の不快感を軽減し、合併症のリスクを最小限に抑えています。また、超音波技術の進歩により、針を刺入する精度が向上し、手技の安全性と成功率が高まっています。さらに、最新の羊水穿刺針の中には、超音波ガイド下での視認性を向上させるエコー源性マーキングなどの機能を備えたものもあります。このような技術的改善により、羊水穿刺はより安全で信頼性の高い手技となり、出生前診療における羊水穿刺の受け入れと利用が増加しています。

規制上および倫理上の考慮点は？

羊水穿刺針の使用は、手技の安全性と有効性を確保するための厳格な規制基準の対象となります。FDAやEMAのような規制機関は、これらの医療機器の承認と監視を監督し、それらが厳格な安全性と品質要件を満たしていることを保証しています。倫理的配慮もまた、特に胎児への潜在的リスクや検査結果の意味合いに関して、重要な役割を果たしています。インフォームド・コンセントは、この検査の重要な側面であり、ヘルスケア提供者は、妊婦の両親に対して、その利点、リスク、起こりうる結果について徹底的に説明することが求められます。さらに、非侵襲的出生前検査（NIPT）の進歩が羊水穿刺の需要に影響を及ぼしています。こうした考慮にもかかわらず、羊水穿刺は依然として出生前診断の重要なツールであり、非侵襲的な方法では必ずしも得られない決定的な診断情報を提供しています。

羊水穿刺針の市場成長の原動力は？

羊水穿刺針市場の成長は、母体年齢の上昇、出生前診断に対する意識の高まり、医療機器の技術進歩など、いくつかの要因によってもたらされます。より多くの女性が人生の後半に子供を持つことを選択するようになり、染色体異常の発生率が増加し、それにより羊水穿刺のような信頼性の高い診断手順への需要が高まっています。より細く、より柔軟な針の開発などの技術革新は、処置の安全性と快適性を高め、その採用を後押ししています。さらに、超音波技術の向上により、より正確な針の設置が容易になり、手技の成功率が高まっています。妊産婦の間で出生前検査に対する認識と受容が高まっていることも、市場の成長に寄与しています。さらに、出生前ケアや診断を促進する政府の取り組みやヘルスケア政策が、羊水穿刺針市場の拡大を後押しする環境を生み出しています。

調査対象企業の例（全14件）

  • Becton, Dickinson and Company
  • Biopsybell Srl
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Laboratoire Ccd
  • Medline Industries, Inc.
  • Medtronic PLC
  • RI.MOS. Srl
  • Rocket Medical PLC
  • Smiths Medical
  • Tsunami Medical

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10271

Global Amniocentesis Needles Market to Reach US$213.0 Million by 2030

The global market for Amniocentesis Needles estimated at US$183.9 Million in the year 2023, is expected to reach US$213.0 Million by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. 150 mm & Above Needles, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end of the analysis period. Growth in the 100 - 150 mm Needles segment is estimated at 1.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$48.6 Million While China is Forecast to Grow at 2.0% CAGR

The Amniocentesis Needles market in the U.S. is estimated at US$48.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$34.3 Million by the year 2030 trailing a CAGR of 2.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 1.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Amniocentesis Needles Market - Key Trends and Drivers Summarized

Why Are Amniocentesis Needles Important in Prenatal Care?

Amniocentesis needles are critical medical instruments used in prenatal diagnosis to collect amniotic fluid for testing. This procedure helps detect chromosomal abnormalities, genetic disorders, and infections in the fetus, providing invaluable information for expecting parents and healthcare providers. Typically performed between the 15th and 20th weeks of pregnancy, amniocentesis involves inserting a thin needle into the amniotic sac through the mother’s abdomen, guided by ultrasound. The collected fluid contains fetal cells and various chemicals produced by the baby, offering a wealth of diagnostic data. The importance of these needles lies in their precision and safety, as the procedure must minimize risk to both the mother and the fetus while yielding accurate results.

How Are Technological Innovations Enhancing Amniocentesis Needles?

Technological advancements are significantly improving the design and functionality of amniocentesis needles. Innovations in material science have led to the development of needles that are thinner, more flexible, and more durable, reducing discomfort for the patient and minimizing the risk of complications. Advances in ultrasound technology have also enhanced the accuracy of needle placement, increasing the safety and success rates of the procedure. Additionally, some modern amniocentesis needles come equipped with features such as echogenic markings that improve visibility under ultrasound guidance. These technological improvements are making amniocentesis a safer and more reliable procedure, thereby increasing its acceptance and usage in prenatal care.

What Are the Regulatory and Ethical Considerations?

The use of amniocentesis needles is subject to stringent regulatory standards to ensure the safety and efficacy of the procedure. Regulatory bodies such as the FDA and EMA oversee the approval and monitoring of these medical devices, ensuring they meet rigorous safety and quality requirements. Ethical considerations also play a significant role, particularly concerning the potential risks to the fetus and the implications of the test results. Informed consent is a crucial aspect of the procedure, with healthcare providers required to thoroughly explain the benefits, risks, and possible outcomes to the expectant parents. Additionally, advancements in non-invasive prenatal testing (NIPT) are influencing the demand for amniocentesis, as some parents may opt for less invasive screening methods. Despite these considerations, amniocentesis remains a vital tool in prenatal diagnosis, offering definitive diagnostic information that non-invasive methods cannot always provide.

What Is Driving Market Growth for Amniocentesis Needles?

The growth in the amniocentesis needles market is driven by several factors, including rising maternal age, increasing awareness of prenatal diagnostics, and technological advancements in medical devices. As more women are choosing to have children later in life, the incidence of chromosomal abnormalities increases, thereby boosting the demand for reliable diagnostic procedures like amniocentesis. Technological innovations, such as the development of thinner and more flexible needles, are enhancing the safety and comfort of the procedure, encouraging its adoption. Additionally, improved ultrasound technologies are facilitating more accurate needle placement, increasing the procedure's success rate. Growing awareness and acceptance of prenatal testing among expectant parents are also contributing to market growth, as more couples seek comprehensive information about their unborn child's health. Furthermore, government initiatives and healthcare policies promoting prenatal care and diagnostics are creating a supportive environment for the expansion of the amniocentesis needles market.

Select Competitors (Total 14 Featured) -

  • Becton, Dickinson and Company
  • Biopsybell Srl
  • Cook Medical LLC
  • CooperSurgical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Laboratoire Ccd
  • Medline Industries, Inc.
  • Medtronic PLC
  • RI.MOS. Srl
  • Rocket Medical PLC
  • Smiths Medical
  • Tsunami Medical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Amniocentesis Needles - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Maternal Age Spurs Growth in Prenatal Diagnostics, Driving Market Growth
    • Technological Innovations in Needle Design Propel Market Expansion
    • Increasing Awareness of Genetic Disorders Expands Addressable Market Opportunity
    • Advances in Ultrasound Technology Strengthen Business Case for Amniocentesis
    • Growing Acceptance of Prenatal Testing Drives Adoption of Amniocentesis Needles
    • Shift towards Minimally Invasive Procedures Throws the Spotlight On Amniocentesis
    • Increasing Healthcare Expenditure Accelerates Demand for Prenatal Care
    • Integration of Echogenic Markings in Needles Propels Growth
    • Rising Incidence of High-Risk Pregnancies Expands Addressable Market
    • Development of Non-Invasive Prenatal Testing (NIPT) Creates Challenges for Traditional Methods
    • Rising Demand for Comprehensive Fetal Health Information Generates Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Amniocentesis Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Amniocentesis Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Amniocentesis Needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Amniocentesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Amniocentesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Amniocentesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Amnioreduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Amnioreduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Amnioreduction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Fetal Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Fetal Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Fetal Blood Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Amnioinfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Amnioinfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Amnioinfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cordocentesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cordocentesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cordocentesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Amniocentesis Needles Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for 150 mm & Above by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for 150 mm & Above by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for 150 mm & Above by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for 100 - 150 mm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for 100 - 150 mm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for 100 - 150 mm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Below 100 mm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Below 100 mm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Below 100 mm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Amniocentesis Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Amniocentesis Needles by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION